Abstract
A novel podophyllotoxin-lonidamine hybrid was synthesized, and evaluated for its in vitro cytotoxicity by CCK-8 assay. The conjugate, Da, exhibited comparable antiproliferative activity in human normal and multidrug-resistance leukemia cancer cells. Flow cytometry suggested that Da could induce G2 phase cycle arrest and apoptosis of resistant K562/VCR cells, simultaneously increase the mitochondrial membrane depolarization. Furthermore, immunocytochemistry showed that Da could significantly disrupt the microtubule organization in K562/VCR cells. Molecular modeling demonstrated that Da was able to bind into the colchicine site of tubulin.
Similar content being viewed by others
References
Chen H, Chen F, Hu W, Gou S (2018) Effective platinum(IV) prodrugs conjugated with lonidamine as a functional group working on the mitochondria. J Inorg Biochem 180:119–128
Cheng WH, Cao B, Shang H, Niu C, Zhang LM, Zhang ZH, Tian DL, Zhang S, Chen H, Zou ZM (2014) Synthesis and evaluation of novel podophyllotoxin derivatives as potential antitumor agents. Eur J Med Chem 85:498–507
Gordaliza M, Castro MA, Miguel del Corral JM, Feliciano AS (2000) Antitumor properties of podophyllotoxin and related compounds. Curr Pharm Des 6:1811–1839
Gordaliza M, Garcı́a PA, Del Corral JM, Castro MA, Gómez-Zurita MA (2014) Podophyllotoxin: distribution, sources, applications and new cytotoxic derivatives. Toxicon 44:441–459
Han HW, Qiu HY, Hu C, Sun WX, Yang RW, Qi JL, Wang XM, Lu GH, Yang YH (2016) Design, synthesis and anti-cancer activity evaluation of podophyllotoxin-norcantharidin hybrid drugs. Bioorg Med Chem Lett 26:3237–3242
Kamal A, Hussaini SMA, Rahim A, Riyaz S (2015) Podophyllotoxin derivatives: a patent review (2012-2014). Expert Opin Ther Pat 25:1025–1034
Kamal A, Kumar BA, Arifuddin M, Dastidar SG (2006) Synthesis and biological activity of new 4β-N-heteroaryl analogues of podophyllotoxin. Lett Drug Des Discov 3:205–209
Liu YQ, Tian J, Qian K, Zhao XB, Morris-Natschke SL, Yang L, Nan X, Tian X, Lee KH (2015) Recent progress on C-4-Modified podophyllotoxin analogs as potent antitumor agents. Med Res Rev 35:1–62
Nath K, Guo L, Nancolas B, Nelson DS, Shestov AA, Lee SC, Roman J, Zhou R, Leeper DB, Halestrap AP, Blair IA, Glickson JD (2016a) Mechanism of antineoplastic activity of lonidamine. Biochim Biophys Acta 1866:151–162
Nath K, Nelson DS, Heitjan DF, Leeper DB, Zhou R, Glickson GD (2015a) Lonidamine induces intracellular tumor acidification and ATP depletion in breast, prostate and ovarian cancer xenografts and potentiates response to doxorubicin. NMR Biomed 28:281–290
Nath K, Nelson DS, Heitjan DF, Zhou R, Leeper DB, Glickson GD (2015b) Effects of hyperglycemia on lonidamine-induced acidification and de-energization of human melanoma xenografts and sensitization to melphalan. NMR Biomed 28:395–403
Nath K, Nelson DS, Putt ME, Leeper DB, Garman B, Nathanson KL, Glickson GD (2016b) Comparison of the lonidamine potentiated effect of nitrogen mustard alkylating agents on the systemic treatment of DB-1 human melanoma xenografts in mice. PLoS ONE 11:e0157125
Nosova YN, Foteeva LS, Zenin IV, Fetisov TI, Kirsanov KI, Yakubovskaya MG, Antonenko TA, Tafeenko VA, Aslanov LA, Lobas AA, Gorshkov MV, Galanski M, Keppler BK, Timerbaev AR, Milaeva ER, Nazarov AA (2017) Enhancing the cytotoxic activity of anticancer PtIV complexes by introduction of lonidamine as an axial ligand. Eur J Inorg Chem 2017:1785–1791
Shareef MA, Duscharla D, Ramasatyaveni G, Dhoke NR, Das A, Ummanni R, Srivastava AK (2015) Investigation of podophyllotoxin esters as potential anticancer agents: synthesis, biological studies and tubulin inhibition properties. Eur J Med Chem 89:128–137
Sun WX, Ji YJ, Wan Y, Han HW, Lin HY, Lu GH, Qi JL, Wang XM, Yang YH (2017) Design and synthesis of piperazine acetate podophyllotoxin ester derivatives targeting tubulin depolymerization as new anticancer agents. Bioorg Med Chem Lett 27:4066–4074
Wang J, Long L, Chen Y, Xu Y, Zhang L (2018) Design, synthesis and antineoplastic activity of novel hybrids of podophyllotoxin and indirubin against human leukaemia cancer cells as multifunctional anti-MDR agents. Bioorg Med Chem Lett 28:1817–1824
Wang ZZ, Sun WX, Wang X, Zhang YH, Qiu HY, Qi JL, Pang YJ, Lu GH, Wang XM, Yu FG, Yang YH (2017) Design, synthesis, biological evaluation, and 3D-QSAR analysis of podophyllotoxin-dioxazole combination as tubulin targeting anticancer agents. Chem Biol Drug Des 90:236–243
Wieczorek A, Błauż A, Makal A, Rychlik B, Plażuk D (2017) Synthesis and evaluation of biological properties of ferrocenyl-podophyllotoxin conjugates. Dalton Trans 46:10847–10858
Xu XH, Guan XW, Feng SL, Ma YZ, Chen SW, Hui L (2017) One-pot synthesis and biological evaluation of N-(aminosulfonyl)-4-podophyllotoxin carbamates as potential anticancer agents. Bioorg Med Chem Lett 27:2890–2894
You Y (2015) Podophyllotoxin derivatives: current synthetic approaches for new anticancer agents. Curr Pharm Des 11:1695–1717
Zhang L, Chen F, Zhang Z, Chen Y, Wang J (2016a) Synthesis and biological evaluation of a novel artesunate-podophyllotoxin conjugate as anticancer agent. Bioorg Med Chem Lett 26:38–42
Zhang L, Zhang Z, Chen F, Chen Y, Lin Y, Wang J (2016b) Aromatic heterocyclic esters of podophyllotoxin exert anti-MDR activity in human leukemia K562/ADR cells via ROS/MAPK signaling pathways. Eur J Med Chem 123:226–235
Zhang X, Rakesh KP, Shantharam CS, Manukumar HM, Asiri AM, Marwani HM, Qin HL (2018) Podophyllotoxin derivatives as an excellent anticancer aspirant for future chemotherapy: a key current imminent needs. Bioorg Med Chem 26:340–355
Zi CT, Yang D, Dong FW, Li GT, Li Y, Ding ZT, Zhou J, Jiang ZH, Hu JM (2015) Synthesis and antitumor activity of novel per-butyrylated glycosides of podophyllotoxin and its derivatives. Bioorg Med Chem Lett 23:1437–1446
Acknowledgements
This work was supported by the Department of Science and Technology of Guizhou Province (No. [2017]1219, [2014]7565, [2014]7557), Ministry of Education “Chunhui Project” Foundation of China (No. Z2015008), “Academic Youth & Innovation Exploration” of Zunyi Medical University and National First-Rate Construction Discipline of Guizhou Province (Pharmacy) (YLXKJS-YX-04).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Zhang, L., Zheng, J., Rong, Y. et al. Synthesis, antitumor evaluation and molecular docking study of a novel podophyllotoxin-lonidamine hybrid. Med Chem Res 27, 2231–2238 (2018). https://doi.org/10.1007/s00044-018-2230-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-018-2230-9